Medical specialists from France tagged as investigators in clinical trials studying Preleukemia

Total 216 results

A. Banos
Seen in:
- Bayonne, FR-Bayonne-CHCOTEBASQUE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
A. Villate
Seen in:
- Tours, FR-Tours cedex-BRETONNEAU
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Adrien CONTEJEAN, MD
Seen in:
- Épagny, Ch Annecy Genevois
Trials:
- NCT05782127 (Principal Investigator)
Conditions:
- Untreated Myelodysplastic Syndrome
Ahmad AL JIJAKLI
Seen in:
- Argenteuil, CH Victor Dupouy
- Argenteuil, FR-Argenteuil-CHARGENTEUIL
Trials:
- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions:
Alice Garnier
Seen in:
- Nantes, CHU Hotel Dieu
- Nantes, CHU Nantes - Hôtel Dieu
Trials:
- NCT04797780 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions:
Ambroise Marcais
Seen in:
- Paris, FR-Paris cedex 15-NECKER
- Paris, Hopital Necker
Trials:
- NCT04027309 (Principal Investigator)
- NCT05444712 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
AME, MD
Seen in:
- Strasbourg, Hôpital Hautepierre
Trials:
- NCT00443339 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
Amé Shanti
Seen in:
- Strasbourg, ICANS Strasbourg
Trials:
- NCT04797780 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
Amine Belhabri
Seen in:
- Lyon, FR-Lyon-LEONBERARD
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Ana BERCEANU
Seen in:
- Besançon, Besançon CHU
- Besançon, CHU Besançon - Hôpital Jean Minjoz
- Besançon, CHU de Besancon
Trials:
- NCT03643042 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
Conditions:
Anaise BLOUET, MD
Seen in:
- Cholet, CH de Cholet
Trials:
- NCT03223961 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
Andrea TOMA, MD
Seen in:
- Créteil, Hopital Henri-Mondor
Trials:
- NCT03223961 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
Anne Banos, MD
Seen in:
- Bayonne, CH de la côte Basque
- Bayonne, Centre Hospitalier de la Cote Basque
- Bayonne, Ch La Cote Basque
- Bayonne, Hematology Service - CH de la cote basque
Trials:
- NCT03503409 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT02066454 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions:
Anne VEKHOFF, Doctor
Seen in:
- Paris, Hôpital Hotel Dieu
Trials:
- NCT00443339 (Sub-Investigator)
Conditions:
- Myelodysplastic Syndromes
Anne Violaine DONCKER, MD
Seen in:
- Cesson, CH de Sevigné
Trials:
- NCT03223961 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
Anne-Laure TAKSIN BRESSOT, MD
Seen in:
- LE Chesnay, Versailles, Hôpital André Mignot
Trials:
- NCT03744390 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes;
- Leukemia Acute Myeloid
Anne-Laure TAKSIN-BRESSOT, MD
Seen in:
- Versailles, Centre Hospitalier de Versailles-Hôpital André Mignot
Trials:
- NCT03503409 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndromes
Antoine THYSS, PU-PH
Seen in:
- Nice, Centre Antoine Lacassagne
Trials:
- NCT01210274 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia
Arnaud Jaccard
Seen in:
- Limoges, CHU de Limoges
- Limoges, FR-Limoges-CHULIMOGES
Trials:
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Arnaud Pigneux
Seen in:
- Pessac, CHU de Bordeaux - Hopital Haut-Leveque
- Pessac, FR-Pessac Cedex-CHUBORDEAUX
- Pessac, Magendie Hopital Haut-Leveque
Trials:
- NCT04027309 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT04067336 (Principal Investigator)
Conditions:
Aspasia Stamatoullas
Seen in:
- Rouen, Centre Henri Becquerel
- Rouen, Centre Henry Becquerel
Trials:
- NCT00424229 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions:
B. Lioure
Seen in:
- Strasbourg, FR-Strasbourg cedex-HAUTEPIERRE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
BASTIE, MD
Seen in:
- Dijon, CHU de Dijon
Trials:
- NCT00443339 (Sub-Investigator)
Conditions:
- Myelodysplastic Syndromes
Benoit de Renzis
Seen in:
- Clermont-Ferrand, CHU Clermont Ferrand / CHU Estaing
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, Clermont-Ferrand CHU
Trials:
- NCT04797780 (Principal Investigator)
- NCT03643042 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT03454984 (Principal Investigator)
Conditions:
Berengere Gruson, MD
Seen in:
- Amiens, CHU Amiens
Trials:
- NCT03223961 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes
BERGER, MD
Seen in:
- Dijon, CHU de Dijon
Trials:
- NCT00443339 (Sub-Investigator)
Conditions:
- Myelodysplastic Syndromes

Clinical Trials on Preleukemia

Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia

Myelodysplasia

Australia
University Hospital, Grenoble
Novartis

Recruiting

Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (LODEFI)

Myelodysplasia

France
Massachusetts General Hospital
Dana-Farber Cancer Institute; Celgene Corporation

Completed

A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia

Myelodysplasia

United States
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Istituto Clinico Humanitas

Completed

Efficacy and Safety of Luspatercept: A Study by Fondazione Italiana Sindromi Mielodisplastiche (FISiM-Luspa)

Myeloid Dysplasia

Italy
Celgene

Completed

Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea

Myelodysplastic Syndrome

Korea, Republic of
University of Chicago

Completed

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

Leukemia | Preleukemia | Advanced Hematologic Malignancies

United States
Technische Universität Dresden

Not yet recruiting

Lifestyle-modifying Interventions in Low-risk MDS Patients (MDS-LIME)

Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies

Recruiting

A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS (EPO-PRETAR)

Myelodysplastic Syndromes

France
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Myelodysplastic Syndrome

United States
Saint-Louis Hospital, Paris, France
University Hospital, Clermont-Ferrand; University Hospital, Grenoble; Hospital...

Completed

Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study (ONIalloMDS)

Myelodysplasia

France

Medical specialists from France tagged as investigators in clinical trials studying Preleukemia

Clinical Trials on Preleukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations